Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Truking Ingenuity Biotechnology, a strategic subsidiary of the publicly traded Truking Technology Limited, is a leading Chinese provider of integrated separation and purification solutions for the global biopharmaceutical industry. The company specializes in downstream bioprocessing equipment, including chromatography systems, ultrafiltration units, and inline dosing systems, catering to laboratory, pilot, and commercial scales. Its core expertise lies in the separation and purification of biological macromolecules such as monoclonal antibodies, vaccines, blood products, and recombinant proteins. Truking Ingenuity leverages a team with backgrounds from international industry leaders and maintains a strategic partnership with Japan's JNC Corporation through a joint technology lab. Recognized as a national-level 'Specialized and Innovative Little Giant' in China, the company serves hundreds of biopharma clients worldwide across Asia, Europe, and the Americas.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Truking Ingenuity Biotechnology.